Representatives Seal

Revised Fiscal Note

H.B. 409

2025 General Session

Medicaid Pharmacy Amendments - As Amended

by Bolinder, Bridger

Senate Seal
General, Income Tax, and Uniform School FundsJR4-4-101
OngoingOne-timeTotal
Net GF/ITF/USF (rev.-exp.) $6,977,800 $(6,982,800) $(5,000)


State GovernmentUCA 36-12-13(2)(c)
Revenues FY2025 FY2026 FY2027
Federal Funds $0 $(32,522,100) $(32,522,100)
Federal Funds, One-time $0 $32,567,100 $0
Total Revenues $0 $45,000 $(32,522,100)

Enactment of this Legislation may impact federal funds to the State by a one-time increase of $45,000 in FY 2026 and an ongoing decrease of ($32,522,100) in FY 2027.


Expenditures FY2025 FY2026 FY2027
General Fund $0 $(6,977,800) $(6,977,800)
General Fund, One-time $0 $6,982,800 $0
Federal Funds $0 $(32,522,100) $(32,522,100)
Federal Funds, One-time $0 $32,567,100 $0
Medicaid ACA Fund $0 $(2,322,900) $(2,322,900)
Medicaid ACA Fund, One-time $0 $2,322,900 $0
Total Expenditures $0 $50,000 $(41,822,800)

Enactment of this bill may cost the State $50,000 one-time total funds ($5,000 General Fund) in FY 2026 and save the State ongoing beginning in FY 2027 ($41,822,800) total funds ($6,977,800 General Fund) from shifting all Medicaid pharmacy benefits to fee-for-service.


FY2025 FY2026 FY2027
Net All Funds (rev-exp) $0 $(5,000) $9,300,700
Local GovernmentUCA 36-12-13(2)(c)

Enactment of this legislation likely will not result in direct, measurable costs for local governments.

Individuals & BusinessesUCA 36-12-13(2)(c)

Enactment of this legislation likely will not result in direct expenditures from tax or fee changes for Utah residents and businesses.

Regulatory ImpactUCA 36-12-13(2)(d)

Enactment of this legislation likely will not change the regulatory burden for Utah residents or businesses.

Performance EvaluationJR1-4-601

This bill does not create a new program or significantly expand an existing program.